Applied DNA Sciences (APDN) Tops Q2 EPS by 25c

Applied DNA Sciences (NASDAQ: APDN) reported Q2 EPS of $0.05, $0.25 better than the analyst estimate of ($0.20). Revenue for the quarter came in at $4.41 million versus the consensus estimate of $4.11 million.

For earnings history and earnings-related data on Applied DNA Sciences (APDN) click here.

You May Also Be Interested In

• Oracle (ORCL) Tops Q1 EPS by 19c, Beats on Revenue; Beats on Cloud Revenue, Offers Q3 EPS Guidance
• RH shares jump after second quarter beat
• RUM Group to raise Northern Data stake to ~98% via share purchase